Abstract 2091P
Background
Nurses provide information and care on cancer treatment side effects prevention and management. Skin toxicities are common side effects and can be associated with treatment dose reduction or discontinuation. Minimizing skin side effects and using photoprotection improve patient outcomes and quality of life.
Methods
The Association Francophone des Soins Oncologiques de Support (AFSOS) and Multinational Association of Supportive Care in Cancer (MASCC) teamed to create consensus recommendations about using dermocosmetics in cancer patients. They assembled a group of international experts from nursing and other disciplines who manage cancer patients. After literature review, the group held a consensus meeting to give guidance on the use of dermocosmetics with oncology treatments.
Results
Dermocosmetics (or cosmeceuticals) are products with therapeutic value in addition to cosmetic. They contain ingredients that can help repair and support the skin barrier by hydrating the skin, maintaining a healthy microbiome. For general recommendations the group agreed: * Start skin care at the same time as cancer interventions known to be associated with skin toxicities, with a goal of preventing and minimizing problems. * Hydration of the skin relieves symptoms and reduces exacerbations of xerosis. * Use cleansers with pH close to 5 and avoid basic or neutral pH cleansers. * Photoprotection should be part of initial recommendations for all Consensus recommendations for the use of dermocosmetics in specific skin toxicities management were also made.
Conclusions
Nurses have an essential role in educating patients about skin care as part of their holistic approach to patient care. This new consensus focuses on the practical and beneficial impact of dermocosmetics to avoid and manage side effects as well as prevent dryness, irritation, and sensitivity. Patient education can help prevent high-grade toxicities and reduce healthcare costs by allowing patients to have an active role in their treatment.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
La Roche Posay.
Disclosure
P. Dielenseger, M. Lacouture, K. Khosrotehrani, G. De Barros Silva, J. Ryan Wolf, E.O. Atenguena, B. Dreno: Financial Interests, Personal and Institutional, Advisory Role: La Roche Posay. D. Kerob: Financial Interests, Personal, Full or part-time Employment: La Roche Posay. All other authors have declared no conflicts of interest.
Resources from the same session
2116P - Preoperative body mass index, waist circumference, and mortality after major cancer surgery: A nationwide cohort study in South Korea
Presenter: Jiwon Yoon
Session: Poster session 06
2117P - Dietary patterns and clinical outcomes in patients with lung cancer: What needs to change
Presenter: Imanuely Borchardt
Session: Poster session 06
2118P - Refeeding syndrome: A prospective analysis in adults admitted to an oncology hospital
Presenter: Filipe Gonçalves
Session: Poster session 06
2119P - The prognostic impact of nutritional assessment and scores in advanced gastric cancer
Presenter: Sara Torresan
Session: Poster session 06
2120P - Nutritional deficiency post gastric cancer surgery
Presenter: Abay Makishev
Session: Poster session 06
2121P - Association between nutritional status and adverse events in gastrointestinal cancer patients undergoing outpatient chemotherapy in Japan
Presenter: Naoko Sato
Session: Poster session 06
2122P - Clinical significance of oncology patients’ nutritional status assessment
Presenter: Efthymios Kostaridis
Session: Poster session 06
2123P - Value of immuno-nutritional scores in the prognosis of hospitalised patients with lung cancer
Presenter: Jesús López
Session: Poster session 06
2124P - The impact of NUTRItional status at first medical oncology visit ON Clinical Outcomes: The NUTRIONCO study
Presenter: Maurizio Muscaritoli
Session: Poster session 06
2125P - Potential ROle of hypoVItaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): A prospective observational study
Presenter: Alessio Cortellini
Session: Poster session 06